Kretowski A, Szelachowska M, Kowalska I, Peczyńska J, Urban M, Kinalska I
Kliniki Endokrynologii Akademii Medycznej w Białymstoku.
Przegl Lek. 1998;55(6):315-9.
Autoantibodies to glutamic acid decarboxylase (GADA)-found frequently before the onset of IDDM are an important marker of the autoimmune process of B cells destruction. The aim of the present study was to evaluate the possible relationship between the frequency of GADA and ICA in first degree relatives of subjects with IDDM. The GADA were determined in 238 first degree relatives of IDDM subjects. In 32 of the investigated subjects GADA were measured second time after 12 months and in 24 of them IVGTT was performed to evaluate FPIR and GADA prevalence relationship. The results demonstrate that combination of ICA and GADA antibodies has a high sensitivity and increases the specificity for predicting IDDM in high risk siblings.
谷氨酸脱羧酶自身抗体(GADA)——常在胰岛素依赖型糖尿病(IDDM)发病前频繁出现——是B细胞破坏自身免疫过程的重要标志物。本研究的目的是评估IDDM患者一级亲属中GADA和胰岛细胞抗体(ICA)频率之间的可能关系。对238名IDDM患者的一级亲属进行了GADA检测。在12个月后对32名受调查对象再次检测GADA,并对其中24人进行静脉葡萄糖耐量试验(IVGTT)以评估第一时相胰岛素分泌反应(FPIR)和GADA患病率之间的关系。结果表明,ICA和GADA抗体联合检测具有高敏感性,并提高了预测高危同胞患IDDM的特异性。